|
128
|
522
|
9q1jB |
Cryo-em structure of sars-cov-2 nsp10-nsp14 e191a mutant-t20p14-r complex |
|
54
|
182
|
9pyzB |
Sars-cov-2 core polymerase complex bound to rna, araump, and utp |
|
193
|
780
|
9oswA |
Tetrameric polq helicase-like domain bound to cmpd 19, a small-molecule atpase inhibitor and drug candidate analog |
|
28
|
131
|
9q1jA |
Cryo-em structure of sars-cov-2 nsp10-nsp14 e191a mutant-t20p14-r complex |
|
28
|
73
|
9pz0C |
Sars-cov-2 core polymerase complex with two utp incorporation |
|
99
|
299
|
9p6pA |
Crystal structure of the sars-cov-2 2'-o-methyltransferase with (m7gpppa)pupu (cap-0) and s-adenosyl-l-homocysteine (sah). |
|
27
|
73
|
9pywC |
Sars-cov-2 nsp7, nsp8 and nsp12 bound to a primer-template pair with incorporated ara-ump |
|
54
|
182
|
9pz0B |
Sars-cov-2 core polymerase complex with two utp incorporation |
|
29
|
73
|
9pyzC |
Sars-cov-2 core polymerase complex bound to rna, araump, and utp |
|
33
|
128
|
9p6pB |
Crystal structure of the sars-cov-2 2'-o-methyltransferase with (m7gpppa)pupu (cap-0) and s-adenosyl-l-homocysteine (sah). |
|
36
|
175
|
9pytA |
Nmr rdc refinement of the catalytic domain of the sars-cov-2 monomeric main protease (mproh41q,10-306) |
|
89
|
306
|
9nskA |
Room-temperature x-ray structure of sars-cov-2 main protease in complex with inhibitor bbh-3 |
|
86
|
306
|
9nslA |
Room-temperature x-ray structure of sars-cov-2 main protease in complex with with inhibitor bbh-4 |
|
88
|
305
|
9n6nA |
Room temperature x-ray structure of sars-cov-2 main protease mutant d48y, p168 deletion in complex with pomotrelvir |
|
89
|
302
|
9n6rA |
Room temperature x-ray structure of sars-cov-2 main protease in complex with ensitrelvir |
|
88
|
305
|
9n6jA |
Room temperature x-ray structure of sars-cov-2 main protease mutant d48y, p168 deletion |
|
88
|
301
|
9n6pA |
Room temperature x-ray structure of sars-cov-2 main protease mutant d48y, p168 deletion in complex with ensitrelvir |
|
83
|
305
|
9n6mA |
Room temperature x-ray structure of sars-cov-2 main protease mutant d48y, p168 deletion in complex with nirmatrelvir |
|
84
|
305
|
9n6lA |
Room temperature x-ray structure of sars-cov-2 main protease mutant d48y, p168 deletion in complex with gc373 |
|
86
|
305
|
9mvmA |
Crystal structure of sars-cov-2 main protease (mpro)in complex with inhibitor avi-3318 |
|
87
|
301
|
9mvqA |
Crystal structure of sars-cov-2 main protease (mpro) variant q192t in complex with inhibitor avi-4303 |
|
91
|
305
|
9mvoA |
Crystal structure of sars-cov-2 main protease (mpro) in complex with inhibitor avi-4692 |
|
77
|
305
|
9mvpA |
Crystal structure of sars-cov-2 main protease (mpro)in complex with inhibitor avi-4516 |
|
76
|
302
|
9m2vA |
Crystal structure of the sars-cov-2 (covid-19) main protease with inhibitor mc12 |
|
78
|
298
|
9kbiA |
The structure of b19v ns1_2-570/dsdna/amppnp |
|
84
|
296
|
9kgqA |
Discovery of an orally bioavailable reversible covalent sars-cov-2 mpro inhibitor with pan-coronavirus activity |
|
75
|
298
|
9kbgA |
The structure of b19v ns1_2-570/amppnp |
|
81
|
299
|
9kgnA |
Discovery of an orally bioavailable reversible covalent sars-cov-2 mpro inhibitor with pan-coronavirus activity |
|
84
|
298
|
9kbjA |
The structure of b19v ns1_200-501/amppnp |
|
83
|
302
|
9kgsA |
Discovery of an orally bioavailable reversible covalent sars-cov-2 mpro inhibitor with pan-coronavirus activity |
|
79
|
298
|
9kgjA |
Discovery of an orally bioavailable reversible covalent sars-cov-2 mpro inhibitor with pan-coronavirus activity |
|
92
|
307
|
9kgrA |
Discovery of an orally bioavailable reversible covalent sars-cov-2 mpro inhibitor with pan-coronavirus activity |
|
61
|
297
|
9kbhA |
The structure of b19v ns1_2-570/ssdna/amppnp |
|
235
|
926
|
9immA |
Sars-cov-2 replication-transcription complex has a dimer architecture (local drtc) in post-capping state |
|
248
|
926
|
9imkA |
Sars-cov-2 replication-transcription complex has a dimer architecture (drtc) in post-capping state |
|
171
|
592
|
9immE |
Sars-cov-2 replication-transcription complex has a dimer architecture (local drtc) in post-capping state |
|
180
|
592
|
9imkE |
Sars-cov-2 replication-transcription complex has a dimer architecture (drtc) in post-capping state |
|
17
|
113
|
9immG |
Sars-cov-2 replication-transcription complex has a dimer architecture (local drtc) in post-capping state |
|
17
|
113
|
9imkG |
Sars-cov-2 replication-transcription complex has a dimer architecture (drtc) in post-capping state |
|
48
|
187
|
9immB |
Sars-cov-2 replication-transcription complex has a dimer architecture (local drtc) in post-capping state |
|
47
|
187
|
9imkB |
Sars-cov-2 replication-transcription complex has a dimer architecture (drtc) in post-capping state |
|
192
|
592
|
9i53A |
Crystal structure of the sars-cov-2 helicase nsp13 in complex with atp |
|
196
|
592
|
9i51A |
Crystal structure of the sars-cov-2 helicase nsp13 in complex with adp |
|
84
|
304
|
9hfxA |
Crystal structure of sars cov-2 3clpro (mpro) with alg-097558 |
|
87
|
303
|
9hfyA |
Crystal structure of sars cov-2 3clpro (mpro) with alg-097078 |
|
124
|
439
|
9gfbD |
Cryoem structure of the human ino80 core-nucleosome complex state n-7 |
|
127
|
443
|
9gfbA |
Cryoem structure of the human ino80 core-nucleosome complex state n-7 |
|
118
|
443
|
9gcgA |
Cryoem structure of the human ino80 core- h2a.z nucleosome complex |
|
125
|
439
|
9ge5D |
Cryoem structure of the human ino80-hexasome complex |
|
129
|
443
|
9ge5A |
Cryoem structure of the human ino80-hexasome complex |
